Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis

Figures & data

Table 1. Patient demographics.

Demographic	Total
Age, median [range]	34.5 [14–78]
Sex, n (%)
Male	30 (71.43)
Female	12 (28.57)

Figure 1. Abnormal incidence of clinical manifestations and laboratory test indices in patients with NK/T-LAHS.

Table 2. Patients’ initial induction therapy.

Initial induction therapy	Total	CR	PR	NR
HLH-94	9	0	3	6
HLH-04	5	0	2	3
Glucocorticoids	5	0	0	5
Chemotherapy for tumors	17	2	5	10

Figure 2. (A) Overall survival curves of patients with NK/T-LAHS. (B) Survival curves of NK/T-LAHS patients undergoing allogeneic hematopoietic stem cell transplantation vs. without allogeneic hematopoietic stem cell transplantation. (C) Survival curves of NK/T-LAHS patients with EBV-positive vs. EBV-negative peripheral blood. (D) Survival curves of NK/T-LAHS patients who achieved OR remission with initial induction therapy or those who did not achieve OR after initial induction therapy.